This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical Research Act.

Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

The initiative, titled 'The Court Is Hers,' eliminates registration fees for girls basketball programs at the YMCA.

Eli Lilly and Company (NYSE: LLY) is one of the top most profitable NYSE stocks to buy now. On August 7, Leerink downgraded ...

Eli Lilly and Company (NYSE: LLY) is one of the Good Stocks to Invest in Now. On August 7, Eli Lilly and Company (NYSE:LLY) ...

Deutsche Bank lowered the firm’s price target on Eli Lilly (LLY) to $900 from $1,010 and keeps a Buy rating on the shares. Published first on ...

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

A mum who admitted that she has illegally put her 13-year-old child on Mounjaro weight loss jabs has spoken out on why she ...

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.